CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas
🛡️

Immunology & Inflammation

92 drugs in pipeline from 10 companies

92

Drugs in Pipeline

10

Companies

7

Upcoming Catalysts

92

Phase 3 Trials

Upcoming Catalysts
Sep '26
CELG-RIPhase 2

Corticosteroid Phase 2 Est. Readout

Corticosteroid
Sep 2026~
CT.gov
00%
Sep '26
AZNCFPhase 2

Tezepelumab Phase 2 Est. Readout

Tezepelumab
Sep 2026~
CT.gov
00%
Sep '26
RHHBYPhase 2

Ocrelizumab Test Formulation Phase 2 Est. Readout

Ocrelizumab Test Formulation
Sep 2026~
CT.gov
00%
Sep '26
TEVAPhase 3

Fp/ABS Phase 3 Est. Readout

Fp/ABS
Sep 2026~
CT.gov
00%
Sep '26
PFEPhase 2

PF-07275315 Phase 2 Est. Readout

PF-07275315
Sep 2026~STALE
CT.gov
00%
Sep '26
NVSEFPhase 2

YTB323 Phase 2 Est. Readout

YTB323
Sep 2026~STALE
CT.gov
00%
Sep '26
BIIBPhase 3
Positive

Litifilimab Phase 3 Est. Readout

Litifilimab
Sep 2026~
CT.gov
Pipeline by Phase
Phase 3
92
Related Conditions
autoimmunerheumatoid arthritislupuspsoriasiscrohnulcerative colitisibdinflammatoryimmuneimmunologyeczemadermatitisankylosing spondylitismultiple sclerosisgrafttransplantrejectionallergyasthma